| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |